Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H D Rosas

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Expert Review of Neurotherapeutics|October 9, 2009
Neuroprotective therapy for Huntington's disease: new prospects and challengesS M Hersch, H D Rosas
The Neurologist|December 3, 2003
10 most commonly asked questions about Huntington's diseaseS M Hersch, H D Rosas
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's diseaseH D Rosas, A S Feigin, Steven M Hersch
Lancet (London, England)|January 30, 1988
Combination therapy after retroviral inoculationR M Ruprecht, M A Gama-Sosa, H D Rosas
Journal of the Neurological Sciences|November 6, 1998
Neurocognitive effects of chronic lead intoxication in Andean childrenS A Counter, L H Buchanan, H D Rosas, et al.
Neurosurgery|June 1, 1997
One-year outcome after decompressive surgery for massive nondominant hemispheric infarctionB S Carter, C S Ogilvy, G J Candia, et al.
Neuroscience|June 1, 2015
Tract-based analysis of white matter degeneration in Alzheimer's diseaseS-H Lee, J-P Coutu, P Wilkens, et al.
Neurology|September 15, 2005
Regional cortical thinning in preclinical Huntington disease and its relationship to cognitionH D Rosas, N D Hevelone, A K Zaleta, et al.
Neuroimage|October 23, 2010
Hippocampal degeneration is associated with temporal and limbic gray matter/white matter tissue contrast in Alzheimer's diseaseD H Salat, J J Chen, A J van der Kouwe, et al.
Neuroimage|July 8, 2009
Age-associated alterations in cortical gray and white matter signal intensity and gray to white matter contrastD H Salat, S Y Lee, A J van der Kouwe, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Expert Review of Neurotherapeutics|October 9, 2009
Neuroprotective therapy for Huntington's disease: new prospects and challengesS M Hersch, H D Rosas
The Neurologist|December 3, 2003
10 most commonly asked questions about Huntington's diseaseS M Hersch, H D Rosas
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's diseaseH D Rosas, A S Feigin, Steven M Hersch
Lancet (London, England)|January 30, 1988
Combination therapy after retroviral inoculationR M Ruprecht, M A Gama-Sosa, H D Rosas
Journal of the Neurological Sciences|November 6, 1998
Neurocognitive effects of chronic lead intoxication in Andean childrenS A Counter, L H Buchanan, H D Rosas, et al.
Neurosurgery|June 1, 1997
One-year outcome after decompressive surgery for massive nondominant hemispheric infarctionB S Carter, C S Ogilvy, G J Candia, et al.
Neuroscience|June 1, 2015
Tract-based analysis of white matter degeneration in Alzheimer's diseaseS-H Lee, J-P Coutu, P Wilkens, et al.
Neurology|September 15, 2005
Regional cortical thinning in preclinical Huntington disease and its relationship to cognitionH D Rosas, N D Hevelone, A K Zaleta, et al.
Neuroimage|October 23, 2010
Hippocampal degeneration is associated with temporal and limbic gray matter/white matter tissue contrast in Alzheimer's diseaseD H Salat, J J Chen, A J van der Kouwe, et al.
Neuroimage|July 8, 2009
Age-associated alterations in cortical gray and white matter signal intensity and gray to white matter contrastD H Salat, S Y Lee, A J van der Kouwe, et al.
Pageof 3